Significant Revenue Growth
Total revenue increased by 20% in the quarter, driven by strong performance across MACI and Burn Care segments.
MACI Record Revenue
MACI generated record second-quarter revenue of nearly $54 million, representing 21% growth versus the prior year and 15% sequential growth versus the prior quarter.
MACI Arthro Surge
MACI Arthro surgeon training exceeded expectations, with approximately 600 surgeons trained, contributing to biopsy and implant growth.
Burn Care Performance Rebound
Epicel biopsies increased nearly 40% over the previous year, with the highest monthly biopsies on record in June.
NexoBrid Growth
NexoBrid saw a strong close to the quarter with the highest number of ordering centers and hospital units ordered since launch, with July orders exceeding June's record numbers.
Adjusted EBITDA Increase
Adjusted EBITDA increased by 112% to over $13 million, indicating strong profitability growth.
Strong Cash Position
The company ended the second quarter with approximately $164 million in cash and investments and no debt.